Brief: Argent BioPharma Reports Agreement For Malta Manufacturing Facility
12/03/2025 01:14
March 12 (Reuters) - Argent BioPharma RGT.AX: EXCLUSIVE AGREEMENT FOR MALTA MANUFACTURING FACILITY-RGT.AX UNDER TERM SHEET, ARGENT BIOPHARMA MUST RECEIVE A MINIMUM CONSIDERATION OF US$1 MILLION UNDER TERM SHEET, ARGENT BIOPHARMA MUST RECEIVE A MINIMUM CONSIDERATION OF US$1 MILLION Further company coverage: RGT.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Enters Long Term Aquiol Licensing And Supply Agreement
Brief: Argent Biopharma Secures A$11M Financing Facility To Complete Strategic Acquisition
Brief: Argent Is Growing Through M&A Projected Merged Company Value Of $100M In Ac8 Asset Acquisition
Australia's Argent BioPharma set for best day in a year on AusCann deal
Brief: Argent Biopharma To Acquire Core Operating Assets And IP Portfolio Of Auscann Group